Loading...

Rebecca Deboer, MD, MA

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
AddressLocation Required
Varies CA 00000
Phone415-885-7276
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CABA06/2005Human Biology
    Northwestern University Feinberg School of Medicine, Chicago, ILMD05/2011
    Northwestern University, Evanston, ILMA03/2014Medical Humanities and Bioethics
    University of Chicago, Chicago, IL06/2016Residency in Internal Medicine
    University of Chicago MacLean Center for Clinical Medical Ethics, Chicago, IL05/2016Fellowship in Clinical Medical Ethics
    University of California San Francisco, San Francisco, CA06/2019Fellowship in Medical Oncology

    Collapse Overview 
    Collapse Overview
    Rebecca (Becky) DeBoer, MD, MA is an Assistant Clinical Professor of Medicine in the Division of Hematology/Oncology at UCSF. She received her BA in Human Biology from Stanford University and her joint MD and MA in Medical Humanities and Bioethics from Northwestern University, and wrote her master’s thesis on The Ethics of Global Cancer Care and Control. She completed residency in internal medicine at the University of Chicago and fellowship at the MacLean Center for Clinical Medical Ethics. During her medical training, she conducted qualitative research on cancer treatment decision-making and research ethics in Mumbai, India, and pursued clinical oncology rotations in Uganda and Nigeria. After residency she worked as an oncology clinician at the Butaro Cancer Center of Excellence in rural Rwanda with Partners In Health, where she was engaged in direct patient care, clinical research, and programmatic initiatives. As an oncology fellow at UCSF and HDFCCC Global Cancer Fellow, she conducted ethics research and implementation science projects in Rwanda and Tanzania with support from a Fogarty GloCal Health Fellowship and a grant from the Greenwall Foundation.

    Dr. DeBoer is a medical oncologist based clinically at Zuckerberg San Francisco General Hospital, where she has a general oncology clinic and a breast oncology clinic. She continues to work in the emerging academic field of Global Oncology as a member of the HDFCCC Global Cancer Program at UCSF. Her research examines ethical issues in oncology care and capacity-building in resource-limited settings, and leverages implementation science and mixed methods to address them. She is currently leading collaborative projects in the following areas: 1) Cross-cultural serious illness communication, including a qualitative study examining clinical decision-making about non-curative cancer therapy in Rwanda and Tanzania and a cultural adaptation of evidence-based communication skills training for the Rwandan setting; 2) Resource allocation and patient prioritization for radiotherapy in Rwanda; 3) Implementation science to enhance oncology care delivery, including clinical guideline implementation in Tanzania and clinical program evaluation of a care delivery system in Rwanda.

    Collapse Research 
    Collapse Research Activities and Funding
    Adaptation and Implementation of Evidence-Based Communication Skills Training at Butaro Hospital in Rwanda
    Conquer Cancer, the ASCO Foundation: 2020 Global Oncology Young Investigator Award: Implementation Science to Address Oncology Care in LMICs P0539944Jul 1, 2020 - Jun 30, 2021
    Role: Principal Investigator
    An Ethical Approach to Routine Tragic Choices: Radiotherapy Allocation in Rwanda
    Greenwall Foundation A131753Jul 1, 2018 - Dec 31, 2020
    Role: Principal Investigator
    University of California Global Health Institute Program for Fellows and Scholars
    NIH/FIC D43TW009343Apr 4, 2012 - Jun 30, 2022
    Role: GloCal Health Fellow

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Applying Lessions Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic. JAMA Oncol. 2020 Aug 06. DeBoer RJ, Fadelu TA, Shulman LN, Van Loon K. PMID: 32761149.
      View in: PubMed   Mentions: 1     Fields:    
    2. Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation. JCO Glob Oncol. 2020 Jul; 6:1093-1102. DeBoer RJ, Shyirambere C, Driscoll CD, Butera Y, Paciorek A, Ruhangaza D, Fadelu TA, Umwizerwa A, Bigirimana JB, Muhayimana C, Nguyen C, Park PH, Mpunga T, Lehmann L, Shulman LN. PMID: 32678711.
      View in: PubMed   Mentions:
    3. Breast cancer treatment: A phased approach to implementation. Cancer. 2020 May 15; 126 Suppl 10:2365-2378. Mutebi M, Anderson BO, Duggan C, Adebamowo C, Agarwal G, Ali Z, Bird P, Bourque JM, DeBoer R, Gebrim LH, Masetti R, Masood S, Menon M, Nakigudde G, Ng'ang'a A, Niyonzima N, Rositch AF, Unger-Saldaña K, Villarreal-Garza C, Dvaladze A, El Saghir NS, Gralow JR, Eniu A. PMID: 32348571.
      View in: PubMed   Mentions: 1     Fields:    
    4. The role of dissemination and implementation science in global breast cancer control programs: Frameworks, methods, and examples. Cancer. 2020 May 15; 126 Suppl 10:2394-2404. Rositch AF, Unger-Saldaña K, DeBoer RJ, Ng'ang'a A, Weiner BJ. PMID: 32348574.
      View in: PubMed   Mentions: 2     Fields:    
    5. Development of a theory-driven implementation strategy for cancer management guidelines in sub-Saharan Africa. Implement Sci Commun. 2020; 1:24. DeBoer RJ, Ndumbalo J, Meena S, Ngoma MT, Mvungi N, Siu S, Selekwa M, Nyagabona SK, Luhar R, Buckle G, Lin TK, Breithaupt L, Kennell-Heiling S, Mushi B, Philipo GS, Mmbaga EJ, Mwaiselage J, Van Loon K. PMID: 32885183.
      View in: PubMed   Mentions:
    6. Palliative Oncologic Care Curricula for Providers in Resource-Limited and Underserved Communities: a Systematic Review. J Cancer Educ. 2019 04; 34(2):205-215. Xu MJ, Su D, Deboer R, Garcia M, Tahir P, Anderson W, Kinderman A, Braunstein S, Sherertz T. PMID: 29264703.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Increasing global access to cancer care: models of care with non-oncologists as primary providers. Lancet Oncol. 2017 08; 18(8):1000-1002. Rubagumya F, Greenberg L, Manirakiza A, DeBoer R, Park PH, Mpunga T, Shulman LN. PMID: 28759361.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    8. No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations. J Oncol Pract. 2016 10; 12(10):e901-e911. Daly B, Hantel A, Wroblewski K, Balachandran JS, Chow S, DeBoer R, Fleming GF, Hahn OM, Kline J, Liu H, Patel BK, Verma A, Witt LJ, Fukui M, Kumar A, Howell MD, Polite BN. PMID: 27601514.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leuk Lymphoma. 2016 10; 57(10):2298-306. DeBoer R, Koval G, Mulkey F, Wetzler M, Devine S, Marcucci G, Stone RM, Larson RA, Bloomfield CD, Geyer S, Mullighan CG, Stock W. PMID: 26892479.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    10. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin Cancer Res. 2015 Feb 15; 21(4):870-81. Keck MK, Zuo Z, Khattri A, Stricker TP, Brown CD, Imanguli M, Rieke D, Endhardt K, Fang P, Brägelmann J, DeBoer R, El-Dinali M, Aktolga S, Lei Z, Tan P, Rozen SG, Salgia R, Weichselbaum RR, Lingen MW, Story MD, Ang KK, Cohen EE, White KP, Vokes EE, Seiwert TY. PMID: 25492084.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    11. Economics of Malignant Gliomas: A Critical Review. J Oncol Pract. 2015 01; 11(1):e59-65. Raizer JJ, Fitzner KA, Jacobs DI, Bennett CL, Liebling DB, Luu TH, Trifilio SM, Grimm SA, Fisher MJ, Haleem MS, Ray PS, McKoy JM, DeBoer R, Tulas KM, Deeb M, McKoy JM. PMID: 25466707.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    12. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015 Feb 01; 21(3):632-41. Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P, Cho J, Lawrence MS, Getz G, Brägelmann J, DeBoer R, Weichselbaum RR, Langerman A, Portugal L, Blair E, Stenson K, Lingen MW, Cohen EE, Vokes EE, White KP, Hammerman PS. PMID: 25056374.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansCells
    13. Identifying the needs of brain tumor patients and their caregivers. J Neurooncol. 2011 Sep; 104(3):737-44. Parvataneni R, Polley MY, Freeman T, Lamborn K, Prados M, Butowski N, Liu R, Clarke J, Page M, Rabbitt J, Fedoroff A, Clow E, Hsieh E, Kivett V, Deboer R, Chang S. PMID: 21311950.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    14. Response of an adult patient with pineoblastoma to vorinostat and retinoic acid. J Neurooncol. 2009 Nov; 95(2):289-292. DeBoer R, Batjer H, Marymont M, Goldman S, Walker M, Gottardi-Littell N, Raizer J. PMID: 19506816.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol. 2009 Feb 01; 27(4):579-84. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, Kabuubi P, Ayers-Ringler J, Rabbitt J, Page M, Fedoroff A, Sneed PK, Berger MS, McDermott MW, Parsa AT, Vandenberg S, James CD, Lamborn KR, Stokoe D, Haas-Kogan DA. PMID: 19075262.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCTClinical Trials